1. Ozen H. Glycogen storage diseases:new perspectives. World J Gastroenterol, 2007, 13(18): 2541-2553 2. Shin YS. Glycogen storage disease:clinical,biochemical, and molecular heterogeneity. Semin Pediatr Neurol, 2006, 13(2): 115-120 3. DiMauro S, Hartwig GB, Hays A, et al. Debrancher deficiency:neuromuscular disorder in 5 adults. Ann Neurol, 1979, 5(5): 422-436 4. Reuser AJ, Kroos MA, Hermans MM, et al. Glycogenosis type Ⅱ(acid maltase deficiency). Muscle Nerve, 1995, 3 : S61-S69 5. Haines JL, Ozelius LJ, McFarlane H, et al. A genetic linkage map of chromosome 17. Genomics, 1990, 8(1): 1-6 6. Ausems MG, Verbiest J, Hermans MP, et al. Frequency of glycogen storage disease type Ⅱ in The Netherlands:implications for diagnosis and genetic counselling. Eur J Hum Genet, 1999, 7(6): 713-716 7. Hudgson P, Gardner-Medwin D, Worsfold M, et al. Adult myopathy from glycogen storage disease due to acid maltase deficiency. Brain, 1968, 91(3): 435-462 8. Katzin LW, Amato AA. Pompe disease:a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy. J Clin Neuromuscul Dis, 2008, 9(4): 421-431 9. Koeberl DD, Kishnani PS, Chen YT. Glycogen storage disease types Ⅰ and Ⅱ: treatment updates. J Inherit Metab Dis, 2007, 30(2): 159-164
……